- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo to AB/FF 400/12 μg, AB 400 μg and FF 12 μg
Total 49 results
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Germany, Poland, Israel, Bulgaria, Czechia, Hungary, Spain, Ukraine, United Kingdom
-
GlaxoSmithKlineCompletedCOVID-19 | SARS-CoV-2Australia, United States, Philippines
-
Rennes University HospitalCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompletedAsthma | Chronic Obstructive Pulmonary Disease COPDUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseRomania, Czech Republic
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Novartis PharmaceuticalsCompletedAsthmaItaly, Germany, France
-
CureVacActive, not recruitingGlioblastomaBelgium, Germany, Netherlands
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium, Germany
-
Trinomab Biotech Co., Ltd.TIGERMED AUSTRALIA PTY LIMITEDCompletedHealthy Adult SubjectsAustralia
-
PegBio Co., Ltd.CovanceCompletedType 2 Diabetes Mellitus (T2DM)United States
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseJapan
-
Tris Pharma, Inc.Forest LaboratoriesCompletedProlonged QTc Interval | PharmacokineticUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Taiwan, Korea, Republic of, Japan, India, Hong Kong, Singapore
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Czechia
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Imcyse SAActive, not recruitingDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Lithuania, Belgium, Italy, Slovenia, Sweden
-
AstraZenecaCompletedAsthmaGermany, United Kingdom
-
Ferring PharmaceuticalsCompletedControlled Ovarian StimulationUnited Kingdom, Denmark, Belgium, Czechia, Spain
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)China, Australia, India
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseSpain, Belgium, Italy, Canada, Denmark, United States
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease - COPDUnited States
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom
-
Orion Corporation, Orion PharmaCompleted
-
AstraZenecaCompletedAsthmaUnited States, South Africa, Hungary, Bulgaria, Czech Republic, Poland
-
Anhui Palo Alto Pharmaceuticals, Inc.RecruitingAllergic RhinitisChina
-
Chiesi Farmaceutici S.p.A.SGS S.A.Recruiting
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Spain, United States, Turkey, Canada, Hungary, Slovakia, Italy, Argentina, Czech Republic, France, Peru
-
NovartisSchering-PloughCompleted
-
AstraZenecaCompletedEfficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsChronic Obstructive Pulmonary Disease (COPD)Germany
-
EsoCap AGFGK Clinical Research GmbH; FGK Representative Service B.V.CompletedEosinophilic EsophagitisSpain, Switzerland, Netherlands, Germany, Poland
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseSpain, United States, Belgium
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Organon and CoTerminated
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NRF2 Gene Mutation | NFE2L2 Gene MutationUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
Merck Sharp & Dohme LLCCompleted
-
Astellas Pharma Global Development, Inc.Yale UniversityCompletedHealthy Volunteers | Pharmacokinetics of ASP3662 | Displacement of RadiotracerUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Organon and CoCompleted
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseGermany, United States, Belgium, Hungary
-
Organon and CoTerminatedModerate to Severe Primary Dysmenorrhea
-
GlaxoSmithKlineCompleted
-
AstraZenecaCompletedAsthma | Efficacy | SafetyGermany, Bulgaria
-
Clark StanfordWithdrawn